z-logo
open-access-imgOpen Access
Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation
Author(s) -
Anastasios Dimou,
SaiHong Ignatius Ou,
Robert C. Doebele
Publication year - 2019
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.19.00013
Subject(s) - adenocarcinoma , mutation , cd74 , medicine , lung , lung cancer , cancer research , biology , cancer , genetics , gene , mhc class ii , major histocompatibility complex

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom